Horizon Therapeutics Public Limited Company (HZNP) has a market capitalization of $26.6B and trades at $116.30. The 52-week range is 116.3-116.34.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 51, Earnings Per Share (EPS) of $2.28, annual revenue of $3.63B.
The stock has a beta of 1.01, operates in the Healthcare sector.
